Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
about
Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain functionLate assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis.Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.Retroviruses have differing requirements for proteasome function in the budding processRole of ESCRT-I in retroviral buddingProteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cellsCrystal structure of the matrix protein VP40 from Ebola virusA role for ubiquitin ligase recruitment in retrovirus releaseEquine infectious anemia virus utilizes host vesicular protein sorting machinery during particle releaseEndophilins interact with Moloney murine leukemia virus Gag and modulate virion productionWrapping up the bad news: HIV assembly and releaseA PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus buddingOrchestrating the Selection and Packaging of Genomic RNA by Retroviruses: An Ensemble of Viral and Host FactorsGenome structure and expression of the ev/J family of avian endogenous viruses.Cospeciation and horizontal transmission of avian sarcoma and leukosis virus gag genes in galliform birdsTsg101, an inactive homologue of ubiquitin ligase e2, interacts specifically with human immunodeficiency virus type 2 gag polyprotein and results in increased levels of ubiquitinated gag.Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction.Avian endogenous retrovirus EAV-HP shares regions of identity with avian leukosis virus subgroup J and the avian retrotransposon ART-CH.A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral buddingLate domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimerasMultiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmissionConditions for copackaging rous sarcoma virus and murine leukemia virus Gag proteins during retroviral budding.A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly.Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retrovirusesThe interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process.Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus.Proper processing of avian sarcoma/leukosis virus capsid proteins is required for infectivityFunctional roles of equine infectious anemia virus Gag p9 in viral budding and infectionCharacterization of Rous sarcoma virus Gag particles assembled in vitro.Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.Ebola virus VP40 late domains are not essential for viral replication in cell cultureAmino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.Virus maturation by budding.Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AGUbiquitin in retrovirus assembly: actor or bystander?The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner
P2860
Q24301430-9538857C-21E8-4C1F-A53E-576E0E9EAF96Q24530772-6EEBC0CA-5DBC-4A7C-8874-D1B714360A35Q24540052-F0C78F16-F37A-4AD2-8B0D-386BF63D720AQ24541306-D23391AF-3973-40A5-B8F3-CF8EF69C5049Q24550599-BE4EE00E-FACA-4951-86FE-FC30C2D9892EQ24554467-AFB22500-590B-4A8C-8338-F7F5B6E3B155Q24555190-0CFE526E-7A12-4BB7-B063-6CDAF4E14D4FQ24599743-001A82EB-3CBB-4913-A155-BC47EB89F2F7Q24642874-AC0380E0-AADD-4413-A926-3C89A8EA6498Q24682537-36F07650-C135-4165-88B9-3F5F7AD97812Q24799654-0251FBAA-AC7C-42A3-AA03-AD6CB19B9E62Q26992150-8D70C00C-18BB-4262-837D-01CC733ED82EQ27863679-E9BD58AD-73BA-45EF-B3EF-5E036BFF1A85Q28074165-62E3C7A3-16E1-472C-99F6-6F40E71DE0D8Q30578156-0763B1BB-7A84-4CE8-90D1-13E04B7D41C9Q30855688-154E5771-23B9-4A59-8ADA-2B55CAA17D05Q30865002-677D8BD4-140E-4665-8DE7-3BCF2EB7533EQ31016943-7EA79B45-DD4F-4380-B68A-B9B19A1599D0Q31444589-FBA66835-434F-4712-B3B5-76381A1771BFQ33643776-7BF8F62E-48EF-4E86-A4A3-E6C7A3731034Q33645178-D05FD606-DC08-47BA-81B3-9E1251A89037Q33652796-0062EB9F-FE4B-48ED-8B5F-C660A4ACC3AEQ33653116-3681AB32-E3AC-4FE5-A298-90DC393BC3DFQ33782770-D57EE3A9-BE16-40C1-B3D6-F7A8F441DAD1Q33783498-A6EC5CE3-0143-4CC0-B673-061A589419BFQ33786274-64EC3688-E034-4455-B58D-75851B9DBA96Q33805303-C5AC9E61-90ED-477C-A130-64B562FD078AQ33809367-B937A45D-2CC6-4465-A006-B3E6C2B8E939Q33826592-F4C7F59B-34E3-4572-8B3C-6716C855BB96Q33835398-D3509427-3ED9-48DE-A124-F108D53C0F11Q33842469-960B2EB5-E473-4893-9277-925CE8200FCFQ33846683-DCCE1C8C-7360-4B1B-BBC4-55A2840FF43AQ33865636-4E01642A-8C14-4B88-8FB5-7A31DC4F3CA9Q33884090-F8D953F9-5D15-423A-A466-73D946A4E825Q33911884-76075CE8-0A19-4E73-A253-340C3B9FEC25Q33987373-86BC56B6-4535-4E6A-AF75-91EC0897E117Q34068037-C591B58B-CD6D-44C5-9FE4-EEEF32491B94Q34083261-68649B3B-1DB3-460A-99AD-5DB44885484AQ34087687-66BC8BF0-CB89-4106-922C-F7910195A8D9Q34104639-7C29C98B-241D-4DE7-B572-5C44A132E4AB
P2860
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
@ast
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
@en
type
label
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
@ast
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
@en
prefLabel
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
@ast
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
@en
P2093
P2860
P1433
P1476
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain
@en
P2093
P2860
P304
P577
1996-08-01T00:00:00Z